PADRÕES DE USO DE VOXELOTOR EM UM ESTUDO MULTICÊNTRICO DO MUNDO REAL DE PACIENTES COM DOENÇA FALCIFORME
B Andemariama, M Idowub, N Shahc, R Drachtmand, A Glarose, M Achebef, A Nerog, F Montealegr-Golcherh, S Curtisi, C Minnitii
a New England Sickle Cell Institute, University of Connecticut Health, Farmington, Estados Unidos
b University of Texas Health McGovern Medical School, Houston, Estados Unidos
c Duke University School of Medicine, Durham, Estados Unidos
d Rutgers Medical School, New Brunswick, Estados Unidos
e Division of Pediatric Hematology/Oncology, Central Michigan University, Detroit, Estados Unidos
f Brigham and Women's Hospital, Harvard Medical School, Boston, Estados Unidos
g University of Texas Southwestern Medical Center, Dallas, Estados Unidos
h Pfizer Inc, New York, Estados Unidos
i Albert Einstein College of Medicine, Bronx, Estados Unidos
Ver másLido
1375
Vezesque se leu este artigo
620
Total PDF
755
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 3 | 12 |
| 2025 11 | 51 | 51 | 102 |
| 2025 10 | 29 | 27 | 56 |
| 2025 9 | 34 | 30 | 64 |
| 2025 8 | 18 | 24 | 42 |
| 2025 7 | 24 | 25 | 49 |
| 2025 6 | 25 | 19 | 44 |
| 2025 5 | 47 | 27 | 74 |
| 2025 4 | 29 | 19 | 48 |
| 2025 3 | 45 | 20 | 65 |
| 2025 2 | 30 | 22 | 52 |
| 2025 1 | 30 | 27 | 57 |
| 2024 12 | 24 | 13 | 37 |
| 2024 11 | 31 | 16 | 47 |
| 2024 10 | 31 | 20 | 51 |
| 2024 9 | 35 | 18 | 53 |
| 2024 8 | 37 | 22 | 59 |
| 2024 7 | 30 | 31 | 61 |
| 2024 6 | 36 | 20 | 56 |
| 2024 5 | 42 | 45 | 87 |
| 2024 4 | 27 | 13 | 40 |
| 2024 3 | 28 | 24 | 52 |
| 2024 2 | 17 | 26 | 43 |
| 2024 1 | 14 | 13 | 27 |
| 2023 12 | 11 | 23 | 34 |
| 2023 11 | 14 | 31 | 45 |
| 2023 10 | 7 | 11 | 18 |
Mostrar tudo
